Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Mereo BioPharma (MREO) Tax Provisions (2023)

Mereo BioPharma (MREO) has disclosed Tax Provisions for 1 consecutive years, with $532000.0 as the latest value for Q4 2023.

  • Quarterly Tax Provisions changed N/A to $532000.0 in Q4 2023 from the year-ago period, while the trailing twelve-month figure was $532000.0 through Sep 2024, changed N/A year-over-year, with the annual reading at $532000.0 for FY2023, 25.91% down from the prior year.
  • Tax Provisions for Q4 2023 was $532000.0 at Mereo BioPharma.
  • The five-year high for Tax Provisions was $532000.0 in Q4 2023, with the low at $532000.0 in Q4 2023.